Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality

View ORCID ProfileCaroline A. King, View ORCID ProfileHonora Englander, P. Todd Korthuis, View ORCID ProfileJoshua A. Barocas, K. John McConnell, View ORCID ProfileCynthia D. Morris, View ORCID ProfileRyan Cook
doi: https://doi.org/10.1101/2020.12.01.20242164
Caroline A. King
1Dept. of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline A. King
  • For correspondence: kingca@ohsu.edu
Honora Englander
2Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Honora Englander
P. Todd Korthuis
2Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua A. Barocas
3Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua A. Barocas
K. John McConnell
4Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia D. Morris
5Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cynthia D. Morris
Ryan Cook
2Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ryan Cook
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Addiction consult services (ACS) engage hospitalized patients with opioid use disorder (OUD) in care and help meet their goals for substance use treatment. Little is known about how ACS affect mortality for patients with OUD. The objective of this study was to design and validate a model that estimates the impact of ACS care on 12-month mortality among hospitalized patients with OUD.

Methods We developed a Markov model of referral to an ACS, post-discharge engagement in SUD care, and 12-month drug-related and non-drug related mortality among hospitalized patients with OUD. We populated our model using Oregon Medicaid data and validated it using international modeling standards.

Results There were 6,654 patients with OUD hospitalized from April 2015 through December 2017. There were 114 (1.7%) drug-related deaths and 408 (6.1%) non-drug related deaths at 12 months. Bayesian logistic regression models estimated four percent (4%, 95% CI= 2%, 6%) of patients were referred to an ACS. Of those, 47% (95% CI= 37%, 57%) engaged in post-discharge OUD care, versus 20% not referred to an ACS (95% CI= 16%, 24%). The risk of drug-related death at 12 months among patients in post-discharge OUD care was 3% (95% CI= 0%, 7%) versus 6% not in care (95% CI = 2%, 10%). The risk of non-drug related death was 7% (95% CI =1%, 13%) among patients in post-discharge OUD treatment, versus 9% not in care (95% CI= 5%, 13%).

Discussion Our novel Markov model reflects trajectories of care and survival for patients hospitalized with OUD. This model can be used to evaluate the impact of other clinical and policy changes to improve patient survival.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported through grants from the National Institutes of Health, National Institute on Drug Abuse (UG1DA015815, UG3DA044831). Grant UL1TR002369 provided support of REDCap, the web application this study used for data collection. Caroline King was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number TL1TR002371. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Oregon Health & Science University's Institutional Review Board approved this study (#00010846).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵1 Financial support for this study was provided in part by the following grants: UG1DA015815 (NIDA), UG3DA044831 (NIDA), UL1TR002369 (NCRR), TL1TR002371 (NCATS). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.

Data Availability

Data may be available pending appropriate data access permissions and approval through OHSU's IRB.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality
Caroline A. King, Honora Englander, P. Todd Korthuis, Joshua A. Barocas, K. John McConnell, Cynthia D. Morris, Ryan Cook
medRxiv 2020.12.01.20242164; doi: https://doi.org/10.1101/2020.12.01.20242164
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality
Caroline A. King, Honora Englander, P. Todd Korthuis, Joshua A. Barocas, K. John McConnell, Cynthia D. Morris, Ryan Cook
medRxiv 2020.12.01.20242164; doi: https://doi.org/10.1101/2020.12.01.20242164

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (197)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5904)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (350)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)